Leidy Alvarado, a PhD student at Purdue University, presented her research on using metabolite profiling to detect recurrent breast cancer earlier. Her research utilized NMR and GC x GC-MS to analyze blood serum metabolites and identify biomarkers. She found that metabolite profiling could detect 75% of recurring breast cancer patients, compared to 16% for the standard CA 27.29 marker, diagnosing recurrences on average 13 months earlier. Her results suggested that earlier detection through combined biomarker analysis could enable improved treatments. The student found Leidy's presentation and message about continuing to learn and lead as a PhD student inspiring.